Immunology and Microbiology
Human Cytomegalovirus
100%
Capsid
67%
Virion
65%
Cytomegalovirus Infection
45%
Virology
40%
Cytomegalovirus
40%
Rous Sarcoma Virus
25%
Viral Replication
24%
Retrovirus
22%
Metabolism
21%
Maturation
20%
Viral Disease
18%
Wild Type
17%
Lipid Metabolism
17%
Host Cell
16%
Severe Acute Respiratory Syndrome Coronavirus 2
16%
Metabolite
14%
Biogenesis
14%
Argininosuccinate Synthetase 1
13%
Hypoxia Inducible Factor 1
13%
Oncovirus
13%
Fatty Acid Metabolism
13%
Exosome
13%
Cryoelectron Tomography
13%
Thrombocyte Release Reaction
13%
Thrombocyte Activation
13%
Cell Metabolism
12%
Fibroblast
11%
Amino Terminal Sequence
10%
Carboxy Terminal Sequence
10%
Endoplasmic reticulum
10%
Precursor
8%
Immunosuppression
8%
Disease Burden
8%
COVID-19
8%
Vaccine Efficacy
8%
Human Pathogen
8%
Platelet
7%
Orphan Nuclear Receptor
6%
Fatty Acid Synthesis
6%
Receptor Gene
6%
Biochemistry, Genetics and Molecular Biology
Human Cytomegalovirus
62%
Capsid
54%
Elongase
28%
Very Long Chain Fatty Acid
28%
Cytomegalovirus
22%
Virion
21%
Lipidome
20%
Enzyme
20%
Maturation
17%
Virus Replication
15%
Retrovirus
15%
Metabolomics
14%
Argininosuccinate Synthetase 1
13%
P97
13%
Mitochondrion
13%
Ubiquitin
13%
Estrogen-Related Receptor
13%
Cryoelectron Tomography
13%
Membrane Lipid
13%
Kynurenine
13%
Hypoxia Inducible Factor 1
13%
Rous Sarcoma Virus
12%
Phosphotransferase
10%
Kinase
10%
N-Terminus
8%
C-Terminus
8%
Fatty Acid Metabolism
8%
Cell Metabolism
7%
Sterol Regulatory Element Binding Protein 1
7%
Lipid
7%
Acyl-CoA
6%
Malonyl-CoA
6%
Lipid Metabolism
6%
Nucleation
6%
Mammalian Target of Rapamycin
6%
Metabolic Pathway
5%
Fatty Acid Synthesis
5%
Precursor
5%
Keyphrases
Rational Discourse
40%
United States
33%
Virology
27%
Virus
27%
Virology Research
23%
Human Oncogenic Viruses
13%
Hydrophobic Residues
13%
Capsid Assembly
13%
Lipid Saturation
13%
COVID-19
13%
Metabolomics
13%
ER-mitochondria Contact Sites
13%
X-domain
13%
Spacer Peptide
13%
Drug Target Discovery
13%
Capsid
10%
Lipidome
9%
Isotope Tracers
8%
Safe Behavior
6%
Respiratory Infection
6%
Disease Burden
6%
Public Concern
6%
Immunosuppression
6%
Vocal
6%
Gain-of-function
6%
Research Conduct
6%
COVID-19 Pandemic
6%
Aid Policy
6%
Human Pathogens
6%
Controversial Issues
6%
Evidence-based
6%
Politicians
6%
Regulatory Structure
6%
Long History
6%
Neurological Impairment
6%
Function Approach
6%
Health Economics
6%
Biosecurity
6%
Biosafety
6%
COVID-19 Crisis
6%
Pandemic Threat
6%
Common Challenges
6%
Lifesaving
6%
Infectious Diseases
6%
Health Security
6%
Metabolic Changes
5%
Antiviral Target
5%
Human Cytomegalovirus
5%
Infected Cells
5%
